12
Participants
Start Date
August 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
delta-9-tetrahydrocannabinol
During the intervention phases, subjects will be randomly allocated to receive 1 of 3 doses Namisol®: 3 mg, 5 mg, 6,5 mg (or placebo) The washout period between the intervention periods will be at least 2 weeks.
Placebo
On each intervention day the subjects will receive the same amount of drugs in order to insure the blinding of the study
Radboud University Medical Centre, department of Geriatrics, Nijmegen
Radboud University Medical Center
OTHER